Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

This early-stage trial tested a combination of two drugs (TQB2928 and anlotinib) in 20 people with advanced bone cancer (osteosarcoma) or other solid tumors that had come back or spread. The goal was to see if the combo could shrink tumors or delay cancer growth. The study was te…

This study tested a new pill called TQB3909 in 19 adults with mantle cell lymphoma that returned or didn't respond to other treatments. The main goal was to find a safe dose and check for side effects. The trial was ended early, so results are limited.

This early-stage study tested the safety of a new drug called AP026 in healthy adults. The trial was stopped early and only 14 people took part instead of the planned 74. The main goal was to check for side effects, not to see if the drug works for diabetes.